Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Sobanski

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Plos One|March 26, 2013
Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndromeDavid Launay, Virginie Dutoit-Lefevre, Emmanuel Faure, et al.
Hormone Molecular Biology and Clinical Investigation|May 21, 2020
Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatmentJean-Baptiste Davion, Sébastien Sanges, Amjad Ghulam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2020
Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort StudySarah Stabler, Jonathan Giovannelli, David Launay, et al.
Autoimmunity Reviews|March 30, 2024
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysisMarie-Elise Martel, Amélie Leurs, David Launay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial HypertensionVincent Sobanski, Jonathan Giovannelli, Bernadette M Lynch, et al.
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
Plos One|July 2, 2015
An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of AutoantibodiesVirginie Dutoit-Lefèvre, Sylvain Dubucquoi, David Launay, et al.
Scientific Reports|September 12, 2023
Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosisSilvia Speca, Meryem-Maud Farhat, Manel Jendoubi, et al.
Rheumatology (Oxford, England)|December 23, 2023
Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisisAurore Collet, Sebastien Sanges, Amjad Ghulam, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Plos One|March 26, 2013
Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndromeDavid Launay, Virginie Dutoit-Lefevre, Emmanuel Faure, et al.
Hormone Molecular Biology and Clinical Investigation|May 21, 2020
Low hormone levels during an attack of systemic capillary leak syndrome normalizing after treatmentJean-Baptiste Davion, Sébastien Sanges, Amjad Ghulam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2020
Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort StudySarah Stabler, Jonathan Giovannelli, David Launay, et al.
Autoimmunity Reviews|March 30, 2024
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysisMarie-Elise Martel, Amélie Leurs, David Launay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial HypertensionVincent Sobanski, Jonathan Giovannelli, Bernadette M Lynch, et al.
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
Plos One|July 2, 2015
An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of AutoantibodiesVirginie Dutoit-Lefèvre, Sylvain Dubucquoi, David Launay, et al.
Scientific Reports|September 12, 2023
Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosisSilvia Speca, Meryem-Maud Farhat, Manel Jendoubi, et al.
Rheumatology (Oxford, England)|December 23, 2023
Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisisAurore Collet, Sebastien Sanges, Amjad Ghulam, et al.
Pageof 8